ChromaCode Stock

ChromaCode is a molecular diagnostics company focusing on bioinformatics.

Sign up today and learn more about ChromaCode Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About ChromaCode Stock

ChromaCode is a molecular diagnostics company focusing on bioinformatics. It leverages patented mathematical methods and algorithmic enhancements to enrich signal processing from life science instrumentation. The company uses this to extract new information on biochemistry reactions and substantially increase the performance capabilities of today’s gold-standard biochemical assays at a very low cost. ChromaCode was founded in 2012, ChromaCode is headquartered in Carlsbad, California.

Funding History

April 2017$12.0M
December 2019$28.0M
May 2020$10.0M
March 2021$6.0M
March 2022$38.0M

Management

Co-Founder & CTO

Aditya Rajagopal

Co-Founder

Axel Scherer

Board Member

Alex Dickinson

VP & CSO

Karen Menge

Vice President, Operations and Data Science

Chris MacDonald

Board Observer

Adam Fine

Board Director

Pat Smerkers

Board Member

Jenny Yip

Co-Founder & Strategic Advisor

Greg Gosch

Board Member

Aditya Rajagopal

Board Member

Jim Blair

Board Member

Justin Klein

Vice President, Finance and Administration

Brett Brown

Press

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo